Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant; pharmaceutical preparations for the treatment of neurological diseases and disorders; pharmaceutical preparations for use in tissue injury and repair; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of joint diseases; pharmaceutical preparations for use in tissue and organ transplantation and for the prevention and treatment of transplant rejection
FORMALIZED
on 12 Jul 2024
SIGMIVY
DIRECT BIOLOGICS LLC
2338102 · 12 Jul 2024
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant; pharmaceutical preparations for the treatment of neurological diseases and disorders; pharmaceutical preparations for use in tissue injury and repair; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of joint diseases; pharmaceutical preparations for use in tissue and organ transplantation and for the prevention and treatment of transplant rejection
Pharmaceutical preparations based upon human allogeneic bone marrow me...